These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9034931)

  • 21. Pathophysiology of iron toxicity.
    Britton RS; Ramm GA; Olynyk J; Singh R; O'Neill R; Bacon BR
    Adv Exp Med Biol; 1994; 356():239-53. PubMed ID: 7887229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron-induced oxidant stress in nonparenchymal liver cells: mitochondrial derangement and fibrosis in acutely iron-dosed gerbils and its prevention by silybin.
    Pietrangelo A; Montosi G; Garuti C; Contri M; Giovannini F; Ceccarelli D; Masini A
    J Bioenerg Biomembr; 2002 Feb; 34(1):67-79. PubMed ID: 11860182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Iron overload and cancer].
    Blanc JF; Bioulac-Sage P; Balabaud C
    Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis.
    Petrillo S; Manco M; Altruda F; Fagoonee S; Tolosano E
    Antioxid Redox Signal; 2021 Aug; 35(6):474-486. PubMed ID: 32689808
    [No Abstract]   [Full Text] [Related]  

  • 25. Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload.
    Montaldo C; Mattei S; Baiocchini A; Rotiroti N; Del Nonno F; Pucillo LP; Cozzolino AM; Battistelli C; Amicone L; Ippolito G; van Noort V; Conigliaro A; Alonzi T; Tripodi M; Mancone C
    Proteomics; 2014 May; 14(9):1107-15. PubMed ID: 24616218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic fibrogenesis.
    Valkova M
    Bratisl Lek Listy; 2002; 103(2):76-85. PubMed ID: 12061025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on hepatic iron overload in chronic hepatitis C patients].
    Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
    Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic fibrogenesis: from within and outwith.
    Henderson NC; Forbes SJ
    Toxicology; 2008 Dec; 254(3):130-5. PubMed ID: 18824072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk factors of fibrosis in nonalcoholic steatohepatitis.
    Fierbinţeanu-Braticevici C; Bengus A; Neamţu M; Usvat R
    Rom J Intern Med; 2002; 40(1-4):81-8. PubMed ID: 15526543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wild Edible Fruit of Prunus nepalensis Ser. (Steud), a Potential Source of Antioxidants, Ameliorates Iron Overload-Induced Hepatotoxicity and Liver Fibrosis in Mice.
    Chaudhuri D; Ghate NB; Panja S; Das A; Mandal N
    PLoS One; 2015; 10(12):e0144280. PubMed ID: 26633891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.
    Hilgard P; Gerken G
    World J Gastroenterol; 2005 Feb; 11(8):1241-4. PubMed ID: 15754414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets.
    Li LX; Guo FF; Liu H; Zeng T
    Cell Mol Life Sci; 2022 Mar; 79(4):201. PubMed ID: 35325321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
    Reeves HL; Burt AD; Wood S; Day CP
    J Hepatol; 1996 Nov; 25(5):677-83. PubMed ID: 8938545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron as a hepatotoxin.
    Stål P
    Dig Dis; 1995; 13(4):205-22. PubMed ID: 8521607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
    Chen RJ; Wu HH; Wang YJ
    Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiology of hepatic fibrosis].
    Vaĺková M
    Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic injury in chronic iron overload. Role of lipid peroxidation.
    Bacon BR; Britton RS
    Chem Biol Interact; 1989; 70(3-4):183-226. PubMed ID: 2663196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.